Anatomy Aortic Quality of Life 
DAIC
MARCH 28, 2024
milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. Aortic stenosis.
DAIC
JANUARY 6, 2025
Harmony TPV system clinical trials demonstrate ease of implant, conformability to the anatomy, and strong clinical and hemodynamic outcomes for congenital heart disease patients up to three years. Harmony TPV U.S. The device is expected to be commercially available across Europe later this month. 1 Hoffman JL, Kaplan S.
DAIC
APRIL 2, 2024
Data from the TRILUMINATE Pivotal trial demonstrated that patients who received TriClip experienced a marked improvement in the severity of their symptoms and quality of life, with benefits sustained at one year. are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S
AMS Cardiology
APRIL 16, 2024
If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. our blog aims to clearly outline this procedure and how it can significantly improve your quality of life. Understanding Aortic Stenosis The aortic valve regulates blood flow from your heart’s main pumping chamber to the rest of your body.
DAIC
APRIL 9, 2024
It is also the first to focus specifically on informing device selection for patients with small aortic annuli, a patient group that is primarily women and has been underrepresented in previous clinical trials for TAVR. There was a huge difference— 32.2 The magnitude of the hemodynamics difference was larger than we expected.”
Expert insights. Personalized for you.
111 
Let's personalize your content